A‐FABP—A Biomarker Associated With the Metabolic Syndrome and/or an Indicator of Weight Change?

[1]  H. Tilg,et al.  Effects of Pronounced Weight Loss on Adiponectin Oligomer Composition and Metabolic Parameters , 2007, Obesity.

[2]  D. Stejskal,et al.  Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome? , 2006, European journal of clinical investigation.

[3]  B. Paulweber,et al.  Cholesteryl Ester Transfer Protein in Metabolic Syndrome , 2006, Obesity.

[4]  González-Yanes Carmen,et al.  Signalling mechanisms regulating lipolysis. , 2006, Cellular Signalling.

[5]  S. Tam,et al.  Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. , 2006, Clinical chemistry.

[6]  S. Kaser,et al.  Effect of pronounced weight loss on the nontraditional cardiovascular risk marker matrix metalloproteinase-9 in middle-aged morbidly obese women , 2005, International Journal of Obesity.

[7]  J. Suttles,et al.  The Fatty Acid-binding Protein, aP2, Coordinates Macrophage Cholesterol Trafficking and Inflammatory Activity , 2005, Journal of Biological Chemistry.

[8]  U. Hanusch-Enserer,et al.  The metabolic syndrome: Effects of a pronounced weight loss induced by bariatric surgery , 2005, Wiener klinische Wochenschrift.

[9]  W. Hermens,et al.  Fatty acid-binding proteins as plasma markers of tissue injury. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[10]  Frank Eisenhaber,et al.  Fat Mobilization in Adipose Tissue Is Promoted by Adipose Triglyceride Lipase , 2004, Science.

[11]  F. Aigner,et al.  Results and Complications after Laparoscopic Adjustable Gastric Banding in Super-obese Patients, using the Swedish Band , 2004, Obesity surgery.

[12]  S. Kaser,et al.  Effects of weight loss on PLTP activity and HDL particle size , 2004, International Journal of Obesity.

[13]  Jeffrey B. Boord,et al.  Combined Adipocyte-Macrophage Fatty Acid–Binding Protein Deficiency Improves Metabolism, Atherosclerosis, and Survival in Apolipoprotein E–Deficient Mice , 2004, Circulation.

[14]  A. Twijnstra,et al.  Brain- and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utility. , 2004, Clinical chemistry.

[15]  L. Makowski,et al.  Fatty acid binding proteins--the evolutionary crossroads of inflammatory and metabolic responses. , 2004, The Journal of nutrition.

[16]  F. Spener,et al.  Fatty acid-binding proteins--insights from genetic manipulations. , 2004, Progress in lipid research.

[17]  B. Paulweber,et al.  Soluble leptin receptor and soluble receptor-bound fraction of leptin in the metabolic syndrome. , 2003, Obesity research.

[18]  F. Aigner,et al.  Laparoscopic Swedish Adjustable Gastric Banding: 6-year Follow-up and Comparison to other Laparoscopic Bariatric Procedures , 2003, Obesity surgery.

[19]  S. Kaser,et al.  Relationship Between Cholesteryl Ester Transfer Protein and Atherogenic Lipoprotein Profile in Morbidly Obese Women , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[20]  S. Kaser,et al.  Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention , 2002, International Journal of Obesity.

[21]  P. Arner.  Insulin resistance in type 2 diabetes: role of fatty acids , 2002, Diabetes/metabolism research and reviews.

[22]  S. Patel,et al.  Characterization of the Functional Interaction of Adipocyte Lipid-binding Protein with Hormone-sensitive Lipase* , 2001, The Journal of Biological Chemistry.

[23]  Jeffrey B. Boord,et al.  Lack of macrophage fatty-acid–binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis , 2001, Nature Medicine.

[24]  Bruce M. Spiegelman,et al.  Uncoupling of Obesity from Insulin Resistance Through a Targeted Mutation in aP2, the Adipocyte Fatty Acid Binding Protein , 1996, Science.

[25]  G. Hellers,et al.  Gastric Banding for Morbid Obesity: Initial Experience with a New Adjustable Band , 1993, Obesity surgery.

[26]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[27]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[28]  J. Suttles,et al.  The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities. , 2005, The Journal of biological chemistry.

[29]  M. Oberwalder,et al.  Results and complications after adjustable gastric banding in a series of 250 patients. , 2001, American journal of surgery.

[30]  S. Bonner-Weir,et al.  Improved glucose and lipid metabolism in genetically obese mice lacking aP2. , 2000, Endocrinology.